MYRIAD GENETICS, INC. Additional Paid in Capital, Common Stock
MYRIAD GENETICS, INC. (MYGN) had Additional Paid in Capital, Common Stock of $1.50 billion as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-07-31
- 2026-06-30: Additional Paid in Capital, Common Stock $1.50B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.49B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.49B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.49B.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $1.50B 10-Q · filed 2026-07-31 |
| 2026-03-31 | $1.49B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.49B 10-Q · filed 2026-07-31 |
| 2025-09-30 | $1.49B 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.47B 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.46B 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.46B 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.45B 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.44B 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.42B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.42B 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.29B 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.28B 10-Q · filed 2023-08-04 |
| 2023-03-31 | $1.26B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.26B 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.25B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.24B 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.23B 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.23B 10-K · filed 2023-03-01 |
| 2021-09-30 | $1.22B 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.18B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.14B 10-Q · filed 2021-05-05 |
| 2020-12-31 | $1.11B 10-K · filed 2022-02-25 |
| 2020-09-30 | $1.10B 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.10B 10-KT · filed 2021-03-16 |
| 2020-03-31 | $1.09B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.09B 10-Q · filed 2020-02-07 |
| 2019-09-30 | $1.08B 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.07B 10-KT · filed 2021-03-16 |
| 2019-03-31 | $1.06B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.05B 10-Q · filed 2019-02-06 |
| 2018-09-30 | $1.05B 10-Q · filed 2018-11-07 |
| 2018-06-30 | $915.40M 10-K · filed 2019-08-13 |
| 2018-03-31 | $889.60M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $871.10M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $859.60M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $851.40M 10-K · filed 2018-08-24 |
| 2017-03-31 | $839.50M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $831.80M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $826.90M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $830.10M 10-K · filed 2017-08-09 |
| 2016-03-31 | $847.00M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $847.80M 10-Q · filed 2016-02-03 |
| 2015-09-30 | $772.30M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $745.40M 10-K · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |